Creating a database of eye images using a holographic laser
Official title: Creation of a Database of Images of the Eye With the Holographic Doppler Laser
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT06644196 · Data updated 2026-11-12
This study is trying to create a detailed collection of eye images using a new laser to help understand blood flow in the eyes of both patients with eye problems and those without any known issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 123 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Drugs / interventions | radiation |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | November 8, 2024 |
| Main results expected | November 7, 2026 |
| Study ends | November 7, 2026 |
| Registry record updated | December 10, 2025 |
| Trial ID | NCT06644196 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with either known ocular pathologies or no significant eye issues.
✕Probably not a fit
Patients with severe ocular conditions that prevent imaging or those who do not meet the age or consent criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a comprehensive database of images and videos of the eye's fundus using a new holographic Doppler laser device. The device is designed to visualize and quantify blood flow in the eye, which is crucial for understanding various retinal pathologies of vascular origin. Participants will undergo imaging procedures at the Hôpital Fondation Adolphe de Rothschild, where the second prototype of the laser will be utilized. The study focuses on patients with known ocular pathologies as well as those without any known eye issues, ensuring a broad understanding of eye vascular health.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of retinal vascular diseases, leading to better patient outcomes.
How similar studies have gone: While this approach is innovative, similar studies using advanced imaging techniques have shown promise in improving the understanding of retinal conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For all participants: * Age ≥ 18 years * Having received informed information about the study and having signed a consent to participate in the study * Affiliated or beneficiary of social insurance For participants with no known ocular pathology: \- No known ocular pathology other than a refractive disorder For patients with optic nerve pathology: \- Patient undergoing ophthalmology consultation for optic nerve pathology in at least one eye (examples: glaucoma, optic neuritis, hereditary optic nerve diseases) For patients with retinal and/or choroidal pathology: \- Patients undergoing ophthalmology consultations for retinal and/or choroidal pathology in at least one eye (examples: diabetic retinopathy, age-related macular degeneration). For patients with retinal vascular pathology: \- Patient undergoing ophthalmology consultation for retinal vascular pathology in at least one eye (e.g. central retinal artery occlusion, central retinal vein occlusion, ocular ischemia syndrome). Exclusion Criteria: * Inability to maintain a stable sitting position * Contraindications to holographic doppler laser : * implanted medical electronic device (pacemaker or other) * history of photosensitivity. * received photo-dynamic therapy (PDT) within the last 3 months. * viral conjunctivitis or any other infectious disease. * skin lesions on the neck or forehead, not allowing contact with a chin strap * patients at high risk of damage from optical radiation (e.g. aphakic patients, or patients with reduced sensitivity to light due to disease of the back of the eye).
Where it's running
-
Hôpital Fondation A. de Rothschild
Paris, France Recruiting
Study contacts
- Principal investigator: Raphaël Lejoyeux, Dr — Hôpital Fondation Adolphe de Rothschild
- Study coordinator: Amélie Yavchitz
- Email: ayavchitz@for.paris
- Phone: 33 148036454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
French validation of the SAHOT outcome tool after subarachnoid hemorrhage
This study tests whether a French version of the SAHOT questionnaire reliably measures outcomes in adults after subarachnoid hemorrhage.
-
Blood RNA biomarkers for ALS using neuron-derived extracellular vesicles
This will try to see if RNA signatures in neuron-derived extracellular vesicles from blood can identify biomarkers in adults with suspected sporadic ALS compared with healthy volunteers.
-
Probenecid for cluster seizures during presurgical epilepsy monitoring
This trial tests whether probenecid can help control clusters of seizures in people with focal epilepsy during presurgical video-EEG monitoring.
-
Onset of myopia in children who are not yet myopic
This study follows children aged 4 to under 9 with no myopia to see how many become nearsighted over time and what factors might influence that shift.
-
Using virtual reality to measure progress during low vision rehabilitation
This project will test a 20-minute virtual reality test (VisionumVR on a Meta Quest 3) to measure functional vision in people with low vision who are starting or undergoing orthoptic rehabilitation.
-
Renal Involvement in Wilson's Disease
This study tests how Wilson's disease affects the kidneys and who might be at risk for kidney problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.